46 results
8-K
EX-1.1
WINT
Windtree Therapeutics Inc
24 Apr 23
Entry into a Material Definitive Agreement
4:40pm
4.19 shall not apply in respect of an Exempt Issuance.
4.20 Research Independence. The Company acknowledges that each Underwriter’s research analysts
8-K
EX-1.1
2z1lvklb 7j
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
424B4
rjecb064s 5qi5hh2qq
21 May 20
Prospectus supplement with pricing info
6:04am